Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Minnesota.
Press releases published on June 23, 2025
Team-M8tes Brings Fandom to the Forefront of Modern Dating
EIN Presswire
·
June 23, 2025
A first-of-its-kind dating app for all sports fans, Team-M8tes™ connects people through shared fandom, stadium check-ins, and the perfect game-day date. MINNEAPOLIS, MN, UNITED STATES, June 23, 2025 /EINPresswire.com/ -- SNG LABS™, a Minnesota-based …
Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025
GlobeNewswire
·
June 23, 2025
How Parkinson’s affects million – and why current treatments are not enough Continuous dopaminergic stimulation (CDS): a next-gen approach to Parkinson’s care Serina’s drug candidate SER-252 is designed to deliver continuous symptom relief Join Serina CEO …
WISeKey’s Subsidiaries WISeSat and SEALSQ Launch New Satellite with SpaceX, Enabling the First-Ever DePIN from Space and Advancing Quantum-Safe Space Communications
GlobeNewswire
·
June 23, 2025
Courtesy of SpaceX WISeKey’s Subsidiaries WISeSat and SEALSQ Launch New Satellite with SpaceX, Enabling the First-Ever DePIN from Space and Advancing Quantum-Safe Space Communications SEALSQ and WISeSat are setting the foundation for a new generation of …
WISeSat.Space and SEALSQ Launch New Satellite with SpaceX, Enabling the First-Ever DePIN from Space, and Advancing Quantum-Safe Space Communications
GlobeNewswire
·
June 23, 2025
Geneva, Switzerland, June 23, 2025 (GLOBE NEWSWIRE) -- Courtesy of SpaceX SEALSQ and WISeSat are setting the foundation for a new generation of cyber-resilient, quantum-ready space systems, redefining global digital trust from orbit SEALSQ Corp (NASDAQ: …
Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders
GlobeNewswire
·
June 23, 2025
TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the “Meeting”), shareholders holding a total of …
Acceleware Announces Strategic Collaboration and Distribution Agreement with Scovan
GlobeNewswire
·
June 23, 2025
CALGARY, Alberta, June 23, 2025 (GLOBE NEWSWIRE) -- Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of cutting-edge radio frequency (RF) power-to-heat technologies targeting process heat for critical minerals, amine …
Red Earth Casino Chooses QCI Chatalytics to Enhance Casino Operations with Integrated AI Solutions
GlobeNewswire
·
June 23, 2025
SAN DIEGO, June 23, 2025 (GLOBE NEWSWIRE) -- Red Earth Casino has chosen Quick Custom Intelligence’s (QCI) Chatalytics platform to revolutionize its casino operations and elevate guest engagement. This AI-powered suite—which includes Slot Copilot, Player …
QFSCOIN launches free Bitcoin cloud mining option compliant with US SEC regulation
GlobeNewswire
·
June 23, 2025
Dover, DE, June 23, 2025 (GLOBE NEWSWIRE) -- Dogecoin (DOGE) just got another jolt of excitement. After Elon Musk dropped a casual but powerful hint about incorporating Dogecoin into the X Payments platform, the meme coin saw a sharp 7% price jump …
Lucas GC Limited Announces Closing of Follow-On Offering
GlobeNewswire
·
June 23, 2025
NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Lucas GC Limited (NASDAQ: LGCL) (“Lucas” or the “Company”), an artificial intelligence (“AI”) technology-driven Platform-as-a-Service (“PaaS”) company with proprietary technologies applied to the human resources …
Lyell Immunopharma to Participate in the H.C. Wainwright “HCW@Home” Series
GlobeNewswire
·
June 23, 2025
SOUTH SAN FRANCISCO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing next-generation CAR T-cell therapies for patients with cancer, announced today that members of its senior management …
Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May 2, 2025 to…
GlobeNewswire
·
June 23, 2025
PALO ALTO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the …
Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™
GlobeNewswire
·
June 23, 2025
MORRISVILLE, N.C., June 23, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced the receipt of an additional $50.0 million …
Onco360 Has Been Selected as a National Specialty Pharmacy Partner for ROMVIMZA™ (vimseltinib)
GlobeNewswire
·
June 23, 2025
LOUISVILLE, Ky., June 23, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a specialty pharmacy partner by Deciphera Pharmaceuticals, LLC for ROMVIMZA™ (vimseltinib), which has been approved by …
Cidara Announces Proposed Public Offering of Common Stock
GlobeNewswire
·
June 23, 2025
SAN DIEGO, June 23, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (“Cidara”) (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced its plans to commence an …
Natural Alternatives International, Inc. Announces Amended and Extended Credit Facility with Wells Fargo Bank
GlobeNewswire
·
June 23, 2025
CARLSBAD, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced the execution of an amended credit …
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 23, 2025
FLORHAM PARK, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in …
iBio Presents Next-Generation Obesity and Cardiometabolic Pipeline Candidates on June 24 Conference Call
GlobeNewswire
·
June 23, 2025
Review of promising Myostatin and Activin E antibody data iBio to announce 3rd target in Astral Bio Collaboration Conference call Tuesday, June 24 at 8:30 a.m. ET SAN DIEGO, June 23, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (Nasdaq: IBIO), an AI-driven …
Terns Pharmaceuticals Presents Positive Data from Phase 1 Study of TERN-601 Once-daily Oral GLP-1R Agonist for Treatment of Obesity at 85th Annual American Diabetes Association Scientific Sessions
GlobeNewswire
·
June 23, 2025
Phase 1 clinical study of TERN-601 demonstrated differentiated profile in 28-day study; topline data were presented in September 2024 Phase 2 FALCON clinical trial of TERN-601 completed enrollment; 12-week data expected in 4Q 2025 FOSTER CITY, Calif., June …
dLocal announces appointment of Independent Board Member
GlobeNewswire
·
June 23, 2025
MONTEVIDEO, Uruguay, June 23, 2025 (GLOBE NEWSWIRE) -- DLocal Limited (“dLocal”, “we”, “us”, and “our”) (NASDAQ:DLO), a technology-first payments platform, today announced the appointment of Will Pruett as an Independent Board Member and well as a member …
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
June 23, 2025
SAN CARLOS, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL …